Summary:
During lung branching morphogenesis, a multipotent progenitor population resides at the tips of bifurcating epithelial tubes that give rise to all lung epithelial cell types (1). Previously (2, 3) , we demonstrated that human pluripotent stem cells (hPSCs) could differentiate into human lung organoids (HLOs), which possessed airway-like structures and alveolar cells, but it was unclear if HLOs possessed a bona fide tip-progenitor population. The goal of the current study was to understand how tip-progenitors are regulated such that this population could be induced in HLO cultures. Using isolated embryonic mouse and human fetal tip-progenitors, we identified factors that promoted long-term growth and maintenance of this population in vitro. Our results showed significant functional and expression differences between mouse and human tip-progenitors, and demonstrated de novo induction of a robust population of budding, SOX9+ progenitor-like cells in HLOs.
Introduction:
During development, the lung undergoes branching morphogenesis, where a series of stereotyped epithelial bifurcations give rise to the branched, tree-like architecture of the adult lung (4) . A population of rapidly proliferating progenitor cells resides at the distal tips of the epithelium throughout the branching process (1,5). Branching morphogenesis and maintenance of the distal tip progenitor cells is regulated by a series of complex mesenchymal-epithelial interactions that involve multiple signaling events, transcription factors, and dynamic regulation of the physical environment (6) (7) (8) (9) (10) (11) (12) (13) .
The molecular regulation of branching morphogenesis has been investigated in depth, with genetic mouse models playing a central role. These studies have identified major roles for several signaling events, including Wnt, Fibroblast Growth Factor (Fgf), Bone Morphogenic Protein (Bmp), Sonic Hedgehog (Shh), Retinoic Acid (RA) and Hippo signaling among others . These studies have shown the importance of epithelial-mesenchymal cross talk for regulating processes such as branching morphogenesis and proximal-distal patterning (6) , and due to the complex and intertwined nature of these signaling networks, perturbations in one pathway affect signaling activity of others (9, 10, 37) . This understanding of murine lung development has been used as a guide to direct differentiation of human pluripotent stem cells into lung lineages and 3-dimensional lung organoids (2, 3, (38) (39) (40) (41) (42) (43) (44) .
Despite the wealth of information gained from murine studies, significant gaps in our understanding of lung development remain, especially in the context of human lung development. For example, it remains unknown how closely developmental processes in the murine lung mirror human lung development. Furthermore, due to the interdependence of mesenchymal and epithelial cell types, and the complex signaling events that interact to control this process, the precise mechanisms that control distal tip progenitor cell maintenance and cell fate differentiation have remained elusive.
These unknowns have been highlighted in our own studies that have attempted to differentiate lung lineages from hPSCs (2) . For example, we have shown that hPSCs can be differentiated into human lung organoids (HLOs) that possess airway-like epithelial structures, but it is not clear if HLOs pass through distal-tip progenitor-like stage, mimicking the normal developmental events in vivo. This gap in knowledge also suggests that robustly predicting cellular outcomes during hPSC-differentiation is still a major challenge. This lack of predictive power may be due, in part, to species-specific differences between the mouse and human lung, to a poor understanding of human fetal lung development, or because the environment controlling the distal-tip progenitor cells is so complex.
The current work aimed to increase our understanding of how multiple growth factor signaling pathways interact to promote maintenance of distal epithelial progenitors in an undifferentiated state. Second, we aimed to elucidate the mechanisms by which distal epithelial progenitor cells of the human fetal lung are maintained in long-term culture. Third, we aimed to use new information gained from ex vivo culture of mouse and human fetal bud-tip progenitors in a predictive manner, in order to differentiate, de novo, distal epithelial lung progenitor-like cells from hPSCs.
Using isolated epithelial distal-tip progenitor cells from mouse and human fetal lungs during branching morphogenesis, we screened growth factors implicated in lung development individually and in combination for their ability to promote tissue expansion and maintenance of progenitor identity in vitro. Our results demonstrated that FGF7 promoted robust growth and expansion of both mouse and human epithelial progenitors, but could not maintain the progenitor population, which underwent differentiation. In the mouse, FGF signaling (FGF7 +/-FGF10) plus either CHIR-99021 (to stabilize β-catenin) or All-trans Retinoic Acid (RA) increased mRNA and protein expression of the distal epithelial progenitor marker, SOX9, and led to long-term growth and improved epithelial architecture in vitro. Synergistic activity of all 4 factors (FGF7/FGF10/CHIR-99021/RA; 4-factor; '4F' conditions) led to the highest mRNA expression of Sox9 in mice, whereas in human fetal lung buds we found that only 3-factors '3F' (FGF7, CHIR-99021, RA) were required to maintain long-term growth and expression of distal epithelial progenitor genes, including SOX9, ID2 and NMYC. Together, these results suggested that FGF, WNT and RA signaling act synergistically to maintain distal progenitor identity in vitro in both mouse and human distal-tip progenitor cells, but that these pathways affected epithelial progenitors in subtly different ways between species. Unexpectedly, our studies also revealed that distal epithelial progenitor cells in the human lung express SOX2, which is exclusively expressed in the proximal airway in mice (45, 46) , identifying an important molecular difference between mouse and human progenitor cells.
When applied to hPSC-derived foregut spheroid cultures, we observed that 3F conditions promoted robust epithelial growth into larger organoid structures. hPSC-derived organoids grown in 3F media developed a patterned epithelium, with proximal airway-like domains and distal epithelial bud-like domains that possessed SOX9/SOX2+ cells with a molecular profile similar to the human fetal lung buds. Taken together, these studies provide an improved mechanistic understanding of human lung epithelial progenitor cell regulation, and highlight the importance of using developing tissues to provide a framework for improving differentiation of hPSCs into specific lineages.
Results:
Isolation and in vitro culture of murine distal lung bud epithelium During branching morphogenesis, the distal epithelial bud tips are comprised of progenitor cells that remain in the progenitor state until the branching program is complete (47) and will give rise to all the mature cell types of the lung epithelium (1). However, the mechanisms maintaining distal progenitors in an undifferentiated state remain unclear. This population of progenitor cells is known to express several transcription factors, including Sox9, Nmyc and Id2 (1, [47] [48] [49] [50] [51] . In order to study this population of cells, epithelial buds were mechanically isolated from lungs of embryonic day (E) 13.5 Sox9-eGFP mice and cultured in a Matrigel droplet ( Figure 1A ). Sox9-eGFP heterozygous lung bud tips were confirmed to have the same level of Sox9 mRNA as their wild type counterparts by QRT-PCR analysis (Figure 1-figure supplement 1A) . The isolated Sox9+ population was confirmed by GFP expression ( Figure 1B ).
FGF7 promotes growth and expansion of distal epithelial lung buds
We sought to identify culture conditions that could support the long-term growth of distal epithelial buds in culture. We identified signaling events from the literature essential for normal mouse lung epithelial development, including FGF signaling (FGF7 and 10) (19,31,52-55); Wnt signaling (14, 16, 30, (56) (57) (58) (59) ; BMP signaling (17, 60) and RA signaling (32, 33, 61, 62) . Many of these signaling events have previously been used for in vitro differentiation of hPSC-derived lung tissue (39) (40) (41) (42) (43) (63) (64) (65) . We performed a low-throughput screen to identify factors that could promote growth of distal bud tips in culture. The screen included FGF7, FGF10, BMP4, All Trans Retinoic Acid (hereafter referred to as 'RA') and CHIR-99021, which inhibits GSK3β and stabilizes β-catenin (βCAT) leading to activation of βCAT-dependent signaling ( Figure 1C ). Treating buds with no growth factors (basal media, control) or individual growth factors showed that FGF7 promoted growth, expansion and survival of isolated buds for up to two weeks ( Figure 1C ). We also conducted an experiment in which all 5 factors (5F) were combined together, with one factor removed at a time ( Figure 1D ). Buds grew robustly in 5F media, whereas removing FGF7 from the 5F media (5F -FGF7) led to a loss of growth, even after 5 days in culture ( Figure 1D ). It was interesting to note that the same concentration of FGF7 and FGF10 did not have the same effect on lung bud outgrowth, since both ligands act on the FGF Receptor 2 (IIIb) isoform (FGFR2IIIb) (66, 67) , and both ligands are present in the lung during branching morphogenesis (19, 21, 68) . Previous studies have offered evidence showing that FGF10 has structural similarities with FGF7, but is differentially regulated by components of the extracellular matrix, which may influence the ease of diffusion of the ligand (69) . To test the possibility that diffusion of ligand through the matrix may explain experimental differences, we treated buds with a 50-fold excess of FGF10 (500ng/mL compared to 10ng/mL). A high concentration of FGF10 led to modest growth of buds and was sufficient to keep buds alive in culture for up to 5 days, but cultures did not exhibit the same level of growth as those treated with low levels of FGF7 ( Figure 1D ).
Initial experimental conditions used FGF7 concentrations based on previous literature (10ng/mL; Figure 1) (39) . We next tested if FGF7 affected growth in a concentration dependent manner by treating isolated buds with increasing concentrations of FGF7 and performing an EdU incorporation assay (Figure 1 figure supplement 1B-C). After one week in culture, cultures were pulsed with EdU for 1 hour prior to Fluorescence Activated Cell Sorting (FACS). Results showed that treating cultures with 50-100 ng/mL of FGF7 increased proliferation significantly above cultures that only received 1-10 ng/mL of FGF7 (Figure 1-figure supplement 1C ). Despite this increase in proliferation, cultures at lower doses of FGF7 appeared qualitatively healthy (Figure 1-figure supplement 1B) . Additionally, expansion of buds in 10ng/mL FGF7 was more robust than 1ng/mL, and cultures appeared less compact and dense compared to higher doses ( Figure 1-figure supplement 1B) . Based on these results, FGF7 was used at a concentration of 10 ng/mL for the remainder of our experiments.
FGF7 promotes growth of Sox9+ progenitors followed by cellular differentiation in long-term lung cultures.
In order to determine if FGF7 was promoting expansion of Sox9+ distal progenitors cells, we performed a lineage trace utilizing Sox9-Cre ER ;Rosa26 Tomato mice. Tamoxifen was given to timed pregnant dams at E12.5, and epithelial lung buds were isolated 24 hours later, at E13.5 ( Figure 1-figure supplement 1E ). Isolated distal buds that were lineage labeled were placed in vitro in basal media (control) or with FGF7. We observed that the Sox9-Cre ER ; Rosa26 Tomato lineage labeled population expanded over time (Figure 1-figure supplement 1F ). After two weeks in culture, FGF7-treated bud cultures were dense and contained cells that stained positive for mature markers of both alveolar cell types (AEC1 -AQP5; AEC2 -SFTPB) and bronchiolar cell types (Clara cells -SCGB1A1; multiciliated cells -Acetylated Tubulin; basal stem cells -P63) although cells in culture were scattered throughout the tissue and appeared to lack spatial organization ( Figure 1E ). None of the cells observed after two weeks in culture were positive for both SFTPC and SCGB1A1, an expression pattern that has been shown to mark bronchioalveolar stem cells (Figure 1-figure supplement  1D ) (70) . Many of these cell types in culture had similar morphologies as cells found at postnatal day 0 of the in vivo mouse lung ( Figure 1F ). We examined the changes of differentiation marker expression over time using QRT-PCR and observed that the length of time in culture led to significant increases in mature alveolar markers Aqp5 and Sftpb, as well as an upward trend in the expression of the club cell marker Scgb1a1. However, time in culture had a less dramatic effect on expression of proximal cell markers Foxj1, p63, and Sox2. The expression of the distal progenitor marker Sox9 was significantly reduced after 3 days in culture and continued to go down as the time in culture increased ( Figure 1H ). Collectively, this data strongly suggests that FGF7 promoted an initial expansion of Sox9+ distal epithelial progenitor cells that subsequently underwent differentiation with longer times in culture.
FGF7, CHIR-99021 and RA act synergistically to maintain the distal progenitor identity in mouse lung buds in vitro
Given that FGF7 promoted robust expansion of distal buds in vitro, but was also permissive for differentiation, we wanted to identify additional growth factors that interacted with FGF signaling to maintain the undifferentiated SOX9+ distal progenitor cell state in vitro. To do this, we returned to the strategy of using 5F media, and removed one additional growth factor at a time to examine the effect on growth, and expression of Sox9 and Sox2 as markers of distal progenitor and proximal airway cells, respectively. Removing any single factor (FGF10, CHIR-99021, RA or BMP4) from '5F' culture media did not affect the ability of isolated buds to expand (Figure 2A ; 5F control condition presented in Figure 1D ). QRT-PCR analysis of buds after 5 days in culture showed that removing BMP4 led to a statistically significant increase in Sox9 expression levels when compared to other culture conditions ( Figure 2B ), and led to gene expression levels that were closest in expression levels of freshly isolated wild type (WT) E13.5 lung buds ( Figure 2B ). Sox2 gene expression was generally low in freshly isolated E13.5 lung buds, and in all culture conditions after 5 days in vitro ( Figure 2B ). We also assessed markers for several genes expressed in differentiating cells (Figure 2 figure supplement 1A-B), and noted that the removal of BMP4 from the 5F media also resulted in a significant increase in Sftpb, and reduced expression in the proximal markers p63, Foxj1 and Scgb1a1 (Figure 2-figure supplement 1A-B) . Collectively, this data suggested that removing BMP4 from the media was ideal for supporting an environment with low expression proximal airway markers and high Sox9.
We next screened combinations of the remaining factors to determine a minimal set that promoted tissue expansion while maintaining the identity of distal epithelial progenitor cells. All conditions included FGF7 (10 ng/mL) due to its ability to potently support proliferation and tissue expansion (Figure 1, Figure 1 figure supplement 1). FGF10 (10 ng/mL), CHIR-99021 (3 uM) and RA (50 nM) were added in combination with FGF7 and the effect on growth, gene and protein expression was observed after two weeks in culture ( Figure 2C -E). We found that all conditions supported robust growth ( Figure 2C ) and expression of Sox9, Id2 and Nmyc, while maintaining low levels of Sox2 ( Figure 2D ). In support of this observation, lineage tracing experiments utilizing Sox9-Cre ER ;Rosa26 Tomato mice, in which Tamoxifen was administered to timed pregnant dams at E12.5 and epithelial lung buds were isolated at E13.5, showed an expansion of labeled progenitors over the 2 week period in culture ( Figure 2 -figure supplement 1E). We noted that explanted buds treated with 4F or 3-Factor conditions ('3F'; FGF7, CHIR-99021, RA) maintained Sox9 mRNA expression at the highest levels, similar to those expressed in freshly isolated epithelial buds at E13.5 ( Figure 2D ). Additional QRT-PCR analysis of differentiation markers further suggested that 3F and 4F conditions promoted optimal expression of distal progenitor identity markers while keeping proximal airway marker gene expression low ( 
Long-term in vitro growth and maintenance of human fetal distal epithelial lung progenitors
Given that almost nothing is known about the functional regulation of human fetal distal lung epithelial progenitor cells, we asked if conditions that maintained mouse distal epithelial progenitors also supported human fetal distal lung progenitor growth and expansion in vitro. Distal epithelial lung buds were enzymatically and mechanically isolated from the lungs of 3 different biological samples at 12 weeks of gestation (84-87 days; n=3) and cultured in a Matrigel droplet ( Figure 3A-B) . Surprisingly, while characterizing the isolated buds, whole mount immunostaining revealed that human bud-tip epithelial progenitors express both SOX9 and SOX2 at 12 weeks ( Figure 3C ). This is in stark contrast to mice, where SOX9 is exclusively expressed in the distal lung-bud epithelium and SOX2 is exclusively expressed in the proximal airway epithelium (50, 51) . Further investigation of paraffin embedded fetal lungs ranging from 10-19 weeks of gestation revealed that SOX2/SOX9 double-positive cells are present in distal epithelial cells until about 14 weeks gestation ( Figure 3D ; Figure 3 -figure supplement 1C). By 16 weeks, SOX9 and SOX2 became localized to the distal and proximal epithelium, respectively, and were separated by a SOX9/SOX2-negaive transition zone, which continued to lengthen throughout development ( Figure 3 -figure supplement 1C ). Similar to isolated mouse lung bud cultures, we observed that FGF7 promoted robust growth in vitro after 2 and 4 weeks, but resulted in reduced growth after 6 weeks in culture ( Figure 3E ). However, all other groups tested permitted expansion and survival of buds in culture for 6 weeks or longer ( Figure 3E ). Human fetal buds exposed to 3F or 4F supported robust protein and mRNA expression of the distal progenitor markers SOX9, ID2
and NMYC ( In stark contrast to results in distal progenitors from mice, SOX2 was also robustly expressed in the 3F and 4F conditions in human fetal buds ( Figure 3H ). Whole mount protein staining of SOX2 and SOX9 in buds treated with 3F media confirmed that almost all cells co-express SOX2 and SOX9, similar to native human lung buds in fetal lungs younger than 16 weeks.
Our analysis demonstrated that 3F and 4F media functioned in a similar manner in human fetal buds, and suggested that the addition of FGF10 to the media did not have a significant effect on bud growth or differentiation. We further examined the effect of FGF10 on human fetal lung buds in culture by exposing them to high concentrations of FGF10 (500ng/mL). We observed that high concentrations of FGF10 induced only modest growth when compared to control conditions (basal media) ( Figure 3-figure supplement 1D ). On the other hand, the addition of a Rho-kinase inhibitor (Y27632) in combination with FGF10, but not alone, promoted growth of buds into larger cyst-like structures ( Figure 3-figure  supplement 1D ). These results further support the notion that even at high concentrations, FGF10 alone does not have strong mitogenic effects on the human distal progenitor epithelium in vitro. Collectively, our data showed that a combination of FGF7, RA and activation of Wnt signaling (via CHIR-99021) is a minimal essential combination that promotes growth and maintain distal progenitor identity in long-term culture.
3F media induces a distal lung bud progenitor-like population of cells in hPSC-derived lung organoids.
Given the robustness by which 3F media supported mouse and human lung bud progenitor growth and identity, we sought to determine whether these culture conditions could promote a distal epithelial lung progenitor-like population from hPSCs. NKX2.1+ ventral foregut spheroids were generated as previously described(2,3), and were cultured in a droplet of Matrigel and overlaid with media containing 3F (FGF7, CHIR-99021, RA). Spheroids were considered to be "day 0" on the day they were placed in Matrigel. Organoids (called Human Lung Organoids; HLOs) grown in 3F media exhibited robust and stereotyped growth patterns and survived in culture for over 16 weeks ( Figure 4A -B, Figure 4 -figure supplement 1A-B). Epithelial structures grew first as cystic structures over the course of 2 weeks, followed by a period of epithelial folding that occurred between weeks 3-4 ( Figure 4A and Figure 4-figure supplement 1C-D) . Around 5-6 weeks in culture, the epithelial structures began forming bud-like structures that resembled human fetal epithelial distal bud tips that underwent bifurcations ( Figure 4A -B, Figure 4 -figure supplement 1D, bottom row). HLOs were passaged by gently removing Matrigel and replating in a fresh droplet while preserving structural integrity. In this way, HLOs were able to grow for over 16 weeks in culture while retaining their original shape. HLOs could also be passaged using mechanical shear through a 27-gauge needle, followed by embedding in fresh Matrigel and 3F media (Figure 4-figure supplement 1E ). Following passage, HLOs robustly re-established many small cysts that were expanded and serially passaged every 7-10 days many times (Figure 4-figure supplement 1F ). The majority of HLO cysts formed from needle passaging were composed of cells with SOX2 and SOX9 nuclear co-staining (Figure 4-figure supplement 1G ), suggesting that a population of SOX2/SOX9 double positive cells can be expanded easily in culture.
HLOs cultured in 3F media exhibited robust Nkx2.1 protein expression, a lung epithelial marker, in all cells ( Figure 4C) ; however, it is worth noting that mRNA expression levels of Nkx2.1 were significantly lower than expression levels in the native human fetal lung (Figure 4-figure supplement 2E ).
In addition to the cystic epithelial phenotype noted above, we also observed organoids that possessed a dense phenotype ( 
Interior regions of 3F HLOs contain secretory cells
Interior regions of the HLOs showed protein staining for SCGB1A1, a marker of club cells, and MUC5AC, a marker of goblet cells, two prominent secretory cell types of the human proximal airway (Figure 4H-I) . We also observed AcetylatedTubulin (AcTub) accumulation on the apical surface of many cells, a marker of multiciliated cells ( Figure 4H) ; however, these cells did not have bona fide cilia. We also observed the build-up of a dark, sticky substance within HLOs beginning around 6-7 weeks of culture ( Figure 4A) , and Periodic Acid Shift, Alcian Blue (PAS/AB) staining suggested that this was secreted mucous. Staining clearly shows cells within the HLOs that are positive for mucin, as well as secreted mucus in the lumen of HLOs, similar to what is seen in the adult human lung ( Figure 4J ).
Removal of CHIR-99021 and RA promotes differentiation within HLOs
Based on our results in the mouse showing that FGF7 was permissive for differentiation (Figure 1 ), we hypothesized that removing CHIR-99021 and RA from HLOs grown in 3F media would reduce the number of progenitor cells and increase differentiation of mature cell types within HLO cultures. Foregut spheroids were collected and grown in 3F media for 42 days and were cultured for an additional 26 days in 3F media (control) or media containing FGF7 only ( Figure 5A ). Morphologically, HLOs cultured in FGF7 lost the peripheral bud-like regions compared to 3F HLOs ( Figure 5B ). At the end of the experiment, cultures were collected and assessed for gene and protein expression. While 3F HLOs maintained budded peripheral regions containing cells with nuclear SOX9 and SOX2, HLOs grown in FGF7-only did not exhibit any SOX9/SOX2 double positive cells and instead contained regions with cells containing cytoplasmic SOX9 and separate regions where cells expressed nuclear SOX2 ( Figure 5C ). QRT-PCR analysis of SOX9 showed no change in the amount of SOX9 transcript, but a significant increase in SOX2 transcript in the FGF7 treated HLOs was observed ( Figure 5D ).
HLOs treated with FGF7 also exhibited an increase in many mature cell types as observed both by protein staining and QRT-PCR analysis. Most strikingly, FGF7-only HLOs exhibited a large increase in the number of MUC5AC positive cells, a dramatic increase the amount of mucous within the HLO lumens ( Figure 5E ), as well as a significant increase in gene expression of MUC5AC ( Figure 5F ). Interestingly, there was not an obvious increase in the number of SCGB1A1+ cells observed by protein staining ( Figure 5I ). Although expression levels of SCGB1A1 were increased almost 100-fold in FGF7-only HLOs over the 3F controls, this difference was not statistically significant ( Figure 5F ). FGF7 treated HLOs also contained cells that stained positive for P63, a marker of basal stem cells ( Figure 5G ), and exhibited a significant increase in mRNA expression of P63 ( Figure 5H ). In contrast, P63+ cells were conspicuously absent from 3F epithelial HLOs. (Figure 5G -H, see also Figure 4H ). Although mRNA expression of the proximal ciliated cell marker FOXJ1 increased significantly in HLOs treated with FGF7-only ( Figure 5O ), obvious FOXJ1 protein expression was not detected by immunofluorescence (negative data not shown).
In addition to an increase expression of multiple proximal airway cell markers, HLOs grown in FGF7-only exhibited an increase in both protein and mRNA expression of the AECII marker SFTPC (Figure 5K-L) and possessed cells that stained positive for the AECI marker PDPN, and had increased gene expression of the AECI marker HOPX. (Figure 5M-N) . Together, these results demonstrate that HLOs grown in 3F media have the ability to generate multiple mature lung cell lineages when CHIR-99021 and RA is removed from the media.
Discussion:
The ability to study human lung development, homeostasis and disease is limited by our ability to carry out functional experiments in human tissues. This has led to the development of many different in vitro model systems using primary human tissue, and using cells and tissues derived from hPSCs (72) . Current approaches to differentiate hPSCs have used many techniques, including the stochastic differentiation of lung-specified cultures into many different cell types (39, 63) , FACS based sorting methods to purify lung progenitors from mixed cultures followed by subsequent differentiation (38, 41, 42) , and by expanding 3-dimensional ventral foregut spheroids into lung organoids (2,3). During normal development, early lung progenitors transition through a SOX9+ distal progenitor cell state on their way to terminal differentiation, and it is assumed that in many hPSC-differentiation studies, NKX2.1-positive cells specified to the lung lineage also transition through a SOX9+ distal epithelial progenitor state prior to differentiating; however, this has not been shown definitively. For example, studies have identified methods to sort and purify Carboxypeptidase-M (CPM)-positive progenitor cells from a mixed population (41, 42) . However, whether or not this population represents a distal epithelial progenitor or is representative of an earlier stage lung progenitor is unknown. Moreover, the specific signaling networks that interact in order to induce and/or maintain this progenitor cell state are not well understood. The current study aimed to elucidate the signaling interactions that are required to maintain and expand the distal progenitor population in mouse and human fetal lungs, and to induce, expand and maintain a population of distal epithelial lung progenitor-like cells from hPSCs. Passing through a distal progenitor cell state is a critical aspect of normal lung epithelial development en route to becoming an alveolar or airway cell type (1), and so achieving this with hPSC-derived models is an important step toward faithfully modeling the full complement of developmental events that take place during lung organogenesis in vivo. Moreover, capturing this cell state in vitro will promote future studies aimed at understanding the precise mechanisms by which progenitor cells make cell fate choices in order to differentiate into mature cell types.
Our study has identified a minimum core group of signaling pathways that synergize to efficiently support the maintenance of mouse and human distal progenitor cells cultured ex vivo, and have used the resulting information to differentiate distal lung progenitor-like cells from hPSCs. The robustness of the findings in mouse and human distal progenitors is highlighted by the ability to accurately predict how hPSCs will respond to 3F conditions. Using isolated embryonic tissue side-by-side with in vitro hPSC differentiation highlights the power of using the embryo as guide, but also shows the strength of hPSCdirected differentiation to confirm an observation. That is, if an experimental finding is truly biologically meaningful, the current work and past findings from others suggest that they can be used in a manner that predicts how a naïve cell will behave in the tissue culture dish (73) (74) (75) . In this context, hPSCs and embryos can be viewed as complementary models that, when paired together, form a virtuous circle of discovery and validation.
Our studies also identified significant species-specific differences between the human and fetal mouse lung. Differences included both gene/protein expression differences, as well as functional differences when comparing how cells responded to diverse signaling environments in vitro. For example, SOX9 is exclusively expressed in the distal lung progenitors and SOX2 is exclusively expressed in the proximal airway in the developing mouse lung. In contrast, the distal progenitors in the human fetal lung robustly express both SOX2 and SOX9 until around 16 weeks of gestation. Others have noted similar differences with regards to expression Hedgehog signaling machinery (76) . These mouse-human differences highlight the importance of validating observations made in hPSCderived tissues by making direct comparisons with human tissues, as predictions or conclusions about human cell behavior based on results generated from the developing mouse lung may be misleading.
Our experimental findings, in combination with previously published work have also raised new questions, which may point to interesting avenues for future studies. Previously, we have shown that HLOs grown in high concentrations of FGF10 predominantly give rise to airway-like tissues, with a small number of alveolar cell types and a lack of alveolar structure (2,3). Here, our results suggest that high concentrations of FGF10 alone do not play a major role in supporting robust growth of human fetal lung buds. When comparing our previously published work and our current work, we also note that HLOs grown in high FGF10 possess abundant P63+ basal-like cells (2), whereas HLOs grown in 3F media lack this population. Similarly, HLOs grown in high-FGF10 lacked secretory cells (2), whereas we find evidence for robust differentiation of club and goblet cells in HLOs grown in 3F media. This data suggests that FGF10 may have different functional roles in the human fetal lung or that there are still unappreciated roles for FGF10 during lung morphogenesis, and also suggest that we still do not fully appreciate how these signaling pathways interact to control cell fate decisions. Collectively, these observations lay the groundwork for future studies.
Taken together, our current work has identified that multiple signals are integrated into a network that is critical for long-term in vitro expansion and maintenance of mouse and human distal lung epithelial progenitors, and we have utilized this information to generate and expand, de novo, a population of distal lung epithelial progenitor-like cells from hPSCs. These conditions maintained progenitor-like cells in HLOs for over 115 days in culture, and generated HLOs that patterned, underwent stereotyped complex epithelial budding, and contained mature secretory cells. We believe this predictive approach will be a valuable tool to more carefully understand how certain environments control the differentiation of hPSCs, and that the HLOs described here can be used broadly to study human lung development, homeostasis and disease.
Methods:
Isolation and culture of mouse lung epithelial buds All animal research was approved by the University of Michigan Committee on Use and Care of Animals. Lungs from Sox9-eGFP (MGI ID:3844824), Sox9CreER;Rosa Tomato/Tomato (MGI ID:5009223 and 3809523)(77), or wild type lungs from CD1 embryos (Charles River) were dissected at embryonic day (E) 13.5, and buds were isolated as previously described (78) . For experiments using Sox9CreER;Rosa Tomato/Tomato mice, 50 ug/g of tamoxifen was dissolved in corn oil and given by oral gavage on E12.5, 24 hours prior to dissection.
Isolation and culture of human fetal lung epithelial buds
All research utilizing human fetal tissue was approved by the University of Michigan institutional review board. Normal human fetal lungs were obtained from the University of Washington Laboratory of Developmental Biology. Distal regions of 12 week fetal lungs were cut into ~2mm sections and isolate as described above.
EdU quantification by Flow Cytometry
Epithelial lung buds were dissected from e13.5 CD1 mice and plated in a matrigel droplet as described above. 3-4 individual buds from one mouse were placed in each droplet and were pooled to serve as a single biological replicate. Three droplets (corresponding to 3 independent biological samples) were assigned to each experimental group, receiving either 1, 10, 50 or 100 ng/mL of FGF7 for 7 days. Media was changed every 2-3 days. Cells were incubated with EdU for 1 hour and stained with the Click-It EdU Alexa Fluor 488 system (ThermoFisher Cat# C10337) according to the manufacturer's instructions. As a control, wells that received 10 ng/mL of FGF7 for 7 days were taken through the EdU steps but were not stained were used to set the gates. For analysis, lung buds were broken into a single cell suspension. 1mL of accutase (Sigma Cat# A6964) was added to a 15mL conical tube containing pooled epithelial buds and cells were incubated at 37 degrees Celsius with frequent visual inspection until clumps of cells were no longer visible. 3mL of basal media (see below) was added to each tube, and cells were centrifuged at 300g for 5 minutes at 4 degrees Celsius. The supernatant was then withdrawn, and cells were resuspended with 1 mL sterile PBS, filtered through a 70 uM strainer to remove any cell clumps and transferred to a cell sorting tube. Flow cytometric analysis was performed on a BD FACSARIA III cell sorter (BD biosciences).
Generation and culture of hPSC-derived lung organoids
The University of Michigan Human Pluripotent Stem Cell Research Oversight (hPSCRO) Committee approved all experiments using human embryonic stem cell (hESC) lines. hESC line UM63-1 (NIH registry #0277) was obtained from the University of Michigan and hESC line H9 (NIH registry #0062) was obtained from the WiCell Research Institute. ES cell lines were routinely karyotyped to ensure normal karyotype and ensure the sex of each line (H9 -XX, UM63-1 -XX). Cells are monitored for mycoplasma infection monthly using the MycoAlert Mycoplasma Detection Kit (Lonza). Stem cells were maintained on hESCqualified Matrigel (Corning Cat# 354277) using mTesR1 medium (Stem Cell Technologies). hESCs were maintained and passaged as previously described (74) and ventral foregut spheroids were generated as previously described (2, 3) . Following differentiation, free-floating foregut spheroids were collected from differentiated stem cell cultures and plated in a matrigel droplet on a 24-well tissue culture grade plate.
Culture media, growth factors and small molecules Growth factors and small molecules
Recombinant Human Fibroblast Growth Factor 7 (FGF7) was obtained from R&D systems (R&D #251-KG/CF) and used at a concentration of 10 ng/mL unless otherwise noted. Recombinant Human Fibroblast Growth Factor 10 (FGF10) was obtained either from R&D systems (R&D #345-FG) or generated in house (see below), and used at a concentration of 10 ng/mL (low) or 500 ng/mL (high) unless otherwise noted. Recombinant Human Bone Morphogenic Protein 4 (BMP4) was purchased from R&D systems (R&D Catalog # 314-BP) and used at a concentration of 10 ng/mL. All-trans Retinoic Acid (RA) was obtained from Stemgent (Stemgent Catalog# 04-0021) and used at a concentration of 50 nM. CHIR-99021, a GSK3β inhibitor that stabilizes β-CATENIN, was obtained from STEM CELL technologies (STEM CELL Technologies Catalog# 72054) and used at a concentration of 3 uM. Y27632, a ROCK inhibitor (APExBIO Cat# A3008) was used at a concentration of 10uM.
Generation and Isolation of human recombinant FGF10
Recombinant human FGF10 was produced in-house. The recombinant human FGF10 (rhFGF10) expression plasmid pET21d-FGF10 in E. coli strain BL21trxB(DE3) was a gift from James A. Bassuk at the University of Washington School of Medicine (79) . E. coli strain was grown in standard LB media with peptone derived from meat, carbenicillin and glucose. rhFGF10 expression was induced by addition of isopropyl-1-thio-β-D-galactopyranoside (IPTG). rhFGF10 was purified by using a HiTrap-Heparin HP column (GE Healthcare, 17040601) with step gradients of 0.5M to 2M LiCl. From a 200 ml culture, 3 mg of at least 98% pure rFGF-10 (evaluated by SDS-PAGE stained with Coomassie Blue R-250) was purified. rFGF10 was compared to commercially purchased human FGF10 (R&D Systems) to test/validate activity based on the ability to phosphorylate ERK1/2 in an A549 alveolar epithelial cell line (ATCC Cat#CCL-185) as assessed by western blot analysis.
RNA extraction and quantitative RT-PCR analysis
RNA was extracted using the MagMAX-96 Total RNA Isolation System (Life Technologies). RNA quality and concentration was determined on a Nanodrop 2000 spectrophotometer (Thermo Scientific). 100 ng of RNA was used to generate a cDNA library using the SuperScript VILO cDNA master mix kit (Invitrogen) according to manufacturer's instructions. qRT-PCR analysis was conducted using Quantitect SYBR Green Master Mix (Qiagen) on a Step One Plus Real-Time PCR system (Life Technologies). Expression was calculated as a change relative to GAPDH expression using arbitrary units, which were calculated by the following equation: [2^(GAPDH Ct -Gene Ct)] x 10,000. A Ct value of 40 or greater was considered not detectable. A list of primer sequences used can be found in Table 1 .
Statistical Analysis
All plots and statistical analysis was done using Prism 6 Software (GraphPad Software, Inc.). For statistical analysis of qRT-PCR results, at least 3 biological replicates for each experimental group were analyzed and plotted with the standard error of the mean. If only two groups were being compared, a two-sided student's T-test was performed. In assessing the effect of length of culture with FGF7 on gene expression in mouse buds ( Figure 1G ), a one-way, unpaired Analysis of Variance (ANOVA) was performed for each individual gene over time. The mean of each time point was compared to the mean of the expression level for that gene at day 0 of culture. If more than two groups were being compared within a single experiment, an unpaired one-way analysis of variance was performed followed by Tukey's multiple comparison test to compare the mean of each group to the mean of every other group within the experiment.
Tissue preparation, Immunohistochemistry and imaging
Paraffin sectioning and staining Mouse bud, human bud, and HLO tissue was fixed in 4% Paraformaldehyde (Sigma) for 2 hours and rinsed in PBS overnight. Tissue was dehydrated in an alcohol series, with 30 minutes each in 25%, 50%, 75% Methanol:PBS/0.05% Tween-20, followed by 100% Methanol, and then 100% Ethanol. Tissue was processed into paraffin using an automated tissue processor (Leica ASP300).
Paraffin blocks were sectioned 5-7 uM thick, and immunohistochemical staining was performed as previously described (80) . A list of antibodies, antibody information and concentrations used can be found in Table 2 . PAS Alcian blue staining was performed using the Newcomer supply Alcian Blue/PAS Stain kit (Newcomer Supply, Inc.) according to manufacturer's instructions.
Whole mount staining
For whole mount staining tissue was placed in a 1.5mL eppendorf tube and fixed in 4% paraformaldehyde (Sigma) for 30 minutes. Tissue was then washed with PBS/0.05% Tween-20 (Sigma) for 5 hours, followed by a 2.5-hour incubation with blocking serum (PBS-Tween-20 plus 5% normal donkey serum). Primary antibodies were added to blocking serum and tissue was incubated for at least 24 hours at 4 degrees Celcius. Tissue was then washed for 5 hours with several changes of fresh PBS-Tween-20. Secondary antibodies were added to fresh blocking solution and tissue was incubated for 12-24 hours, followed by 5 hours of PBS-Tween-20 washes. Tissue was then dehydrated to 100% methanol and carefully moved to the center of a single-well EISCO concave microscope slide (ThermoFisher Cat# S99368) using a glass transfer pipette. 5-7 drops of Murray's clear (2 parts Benzyl alcohol, 1 part Benzyl benzoate [Sigma]) were added to the center of the slide, and slides were coverslipped and sealed with clear nail polish.
Imaging and image processing
Images of fluorescently stained slides were taken on a Nikon A-1 confocal microscope. When comparing groups within a single experiment, exposure times and laser power were kept consistent across all images. All Z-stack imaging was done on a Nikon A-1 confocal microscope and Z-stacks were 3-D rendered using Imaris software. Brightness and contrast adjustments were carried out using Adobe Photoshop Creative Suite 6 and adjustments were made uniformly among all images.
Brightfield images of live cultures were taken using an Olympus S2X16 dissecting microscope. Image brightness and contrast was enhanced equally for all images within a single experiment using Adobe Photoshop. Images were cropped where noted in figure legends to remove blank space surrounding buds or cultures. Brightfield images of Alcian Blue stains were taken using an Olympus DP72 inverted microscope. (C) Cultured buds were pulse labeled for 1 hour with EdU and the percent of total cell labeled was quantified by Flow Cyotometry. Low doses of FGF7 (1-10ng/mL) had a similar proportion of cells labeled whereas treatment with 50-100 ng/mL resulted in a significant increase in labeled cells. Each data point represents an independent biological replicate.
(D) Lung bud explants grown in FGF7 for two weeks did not contain cells that were double positive for SCGB1A1 and SFTPC indicating that the explants did not possess bronchoalveolar stem cells (81) . Scale bar represents 50um.
(E) Sox9-Cre ER ;Rosa26 Tomato lungs were induced with Tamoxifen 24 hours prior to isolation of the buds, which were isolated and cultured at E13.5. Lineage labeled buds demonstrated that labeled cells expanded in culture over the course of two weeks. Asterisks (*) mark air bubbles within Matrigel droplets that were auto-fluorescent, and arrowheads point to day 0 isolated lung buds. Scale bar represents 200um. (A-B) Buds were explanted and grown with 5F media minus one growth factor to identify conditions that allowed buds to expand (A) and maximized of expression of Sox9 mRNA (B). Removing BMP4 from the 5F media (5F-BMP4) led to a significant increase in Sox9 expression after 5 days when compared to the full 5F media and resulted in expression levels closest to those of freshly isolated E13.5 lung buds. All groups exhibited low levels of Sox2 expression. Each data point in (B) represents an independent biological replicate. Scale bar represents 200um. (C-D) After removing BMP4, the minimum combination of factors that interact with FGF7 to promote growth (C) and maintain high expression of distal progenitor markers was assessed. Treatment with '4F' media (FGF7/FGF10/CHIR-99021/RA) or '3F' media (FGF7/CHIR-99021/RA) led to growth and had the highest levels of Sox9 expression when compared to FGF7 alone. All groups exhibited maintenance of the progenitor markers Id2 and Nmyc and had low levels of proximal marker Sox2. Each data point in (D) represents an independent biological replicate. Scale bar represents 500um. (E-F) Section and whole mount immunohistochemical staining analysis confirmed that 3F and 4F conditions maintained robust SOX9 protein staining. (A-B) E13.5 mouse lung buds were explanted and grown with 5F media, and 5F minus one growth factor. Gene expression was examined in each condition after 2 weeks in culture for differentiation markers of alveolar cell types (A) and airway cell types (B), including Aqp5 (AECI), Sftpb (AECII), p63 (basal cell), Foxj1 (multiciliated cells), Scgb1a1 (club cells). Each data point represents an independent biological replicate.
(C-D) E13.5 mouse lung buds were explanted and grown with different combinations of growth factors, including '4F' media (FGF7/FGF10/CHIR-99021/RA) or '3F' media (FGF7/CHIR-99021/RA), in addition to FGF7/CHIR-99021 and FGF7/RA. Gene expression for proximal airway markers (C) and maintained levels of mature proximal (C) and distal alveolar (D) markers were assessed after 2 weeks in culture. Each data point represents an independent biological replicate. (E) Sox9-Cre ER ;Rosa26 Tomato lungs were induced with Tamoxifen 24 hours prior to isolation of the buds, which were isolated and cultured at E13. 5 . Lineage labeled buds demonstrated that labeled cells expanded in culture over the course of two weeks in all conditions tested. Scale bar represents 200um. (F) To identify whether cultured lung buds were able to undergo phenotypic maturation, buds were grown for 5 days in 4F media and then either maintained for an additional 4 days in 4F media or switched to FGF7 alone. Scale bar represents 200um. (G) After 9 days in culture (as shown in (F)), protein staining for SOX9, SFTPC and AQP5 was carried out (top row), and staining was compared to in vivo developing lungs at E16.5 and P0 (bottom row). Buds grown for 9 days in 4F media possessed many cells that co-expressed SOX9/SFTPC or SOX9/AQP5 whereas those grown in FGF7 media alone contain cells that are positive for AQP5 or SFTPC, but do not express SOX9. Phenotypically, in vitro grown buds that are exposed to FGF7 alone are similar to AQP5+ AECI and SFTPC+ AECII cells in the P0 mouse lung in vivo. Scale bar represents 50um (H-J) QRT-PCR analysis after 9 days in culture (as shown in (F)) confirms that Sox9 expression is reduced in buds that are switched to FGF7 media compared to 4F media (H), while the club cell marker Scgb1a 1was increased (J) in buds switched to FGF7 media. Significant changes in other markers were not observed (I-J). Each data point in (H-J) represents an independent biological replicate. (C) Freshly isolated buds were immunostained for SOX9, SOX2, ECAD and DAPI and wholemount imaged. Z-stacks were 3D rendered, and resulting images demonstrated overlapping SOX2 and SOX9 expression at bud tips. Scalebar represents 100um. (D) Overlapping SOX9/SOX2 protein expression at distal bud tips was confirmed in formalin fixed, paraffin embedded sections from a 14 week old human fetal lung specimen. (E) Isolated human fetal lung buds were cultured for over 6 weeks various media combinations (optimized in mouse lung bud cultures as shown in Figures 1 and  2 ) to determine conditions that supported tissue growth/expansion. FGF7 alone supported an initial expansion of buds, but the tissue stopped expanding beyond the 4 week period. All other combinations appeared to support robust lung bud expansion up to 6 weeks in culture. Scale bar represents 500um. (F-G) Immunostaining in sections (F) or in wholemount (G) demonstrated that lung buds expanded in 3F or 4F media after 4 weeks in vitro maintained robust co-expression of SOX9 and SOX2. FGF7 grown buds expressed both markers, but strong cytoplasmic SOX9 localization was observed. FGF7/CHIR-99021 and FGF7/RA conditions showed weak staining. Scalebar in (F) represents 50um, and in (G) represents 100um. (H) QRT-PCR analysis after 4 weeks in vitro showed that 3F and 4F conditions maintained the highest levels of SOX9, which were not significantly different from levels seen in the human fetal lung (H), while also maintaining robust expression of distal progenitor markers SOX2, NMYC and ID2 when compared to FGF7 alone, FGF7/CHIR-99021 or FGF7/RA.
Each data point represents an independent biological replicate. (A) Human fetal epithelial buds expanded in different media combinations were assessed for differentiation markers using QRT-PCR after 4 weeks in culture. FGF7-only media led to significantly increased expression of the proximal airway markers P63 and SCGB1A1 compared to the 14 week old human fetal lung ('Fetal'), whereas treatment with 3F or 4F media kept the expression levels of mature proximal markers P63, FOXJ1 and SCGB1A1 at or below the levels seen in human fetal lung. Each data point represents an independent biological replicate. (B) Treatment with 3F or 4F media significantly increased the expression of the AECII marker SFTPB compared to human fetal lung expression and FGF7-only, but did not lead to increased expression of the AECI marker HOPX. (C) Paraffin embedded sections from human fetal lung specimens from 10-20 weeks demonstrate that distal epithelial progenitor regions are SOX9/SOX2 double-positive until 14 weeks, but lose this property sometime between 14 and 16 weeks gestation. By 16 weeks distal buds are SOX9+/SOX2-and a clear transition zone is established where cells are negative for both SOX2 and SOX9. Scale bar represents XXum. (D) High concentrations of FGF10 do not lead to expansion of human fetal lung buds. Isolated tip-progenitors were cultured with in basal media or 500 ng/mL of FGF10. Bud tips were observed to form small cysts in FGF10 at this concentration; however, expansion of the tissue was not robust. Similarly, bud tips treated with the Rho-kinase (Rock) inhibitor Y27632 did not lead to tissue expansion; however, treatment with FGF10 (500ng/mL) plus Y27632 led to robust cyst formation and tissue expansion. This indicated that the effect of high concentrations of FGF10 alone had limited effects on isolated human fetal buds. Dashed lines highlight the Matrigel droplet.
